Following appeals from investors, California has postponed the deadline for venture capital firms to report the demographic details of the startup founders they support. This move delays the implementation of the law aimed at increasing transparency around diversity in venture funding.
Generare, a Paris-based techbio firm, is pioneering the analysis of microbial genomes to discover molecules shaped by three billion years of evolution. The company asserts that in 2025 it has identified more novel small molecules than any other research group combined. Its recent Series A funding round, co-led by Alven and Daphni, supports its mission to accelerate drug development by tapping into this largely unexplored microbial chemistry.
In today's fierce AI landscape, where investment deals fuel the rapid growth of AI technologies, major players like OpenAI, Anthropic, Microsoft, NVIDIA, Google, and Amazon are often in the spotlight. However, behind the scenes, Meta is developing Avocado, a new AI model that holds promising potential. Despite the dominance of existing large language models, Avocado could bring new innovations to the field. More details will follow as this story develops.
Paris-based startup Omniscient has raised $4.1 million in a pre-seed round led by Seedcamp, with support from a global syndicate including investors from France, Japan, and the US. Founded by two former McKinsey consultants, Omniscient offers an AI-driven decision intelligence platform that ingests over 100,000 sources such as press, social media, web, video, audio, and internal data streams. This platform synthesizes information into concise two-minute executive briefings, enabling boards and senior executives to monitor corporate reputation in real time. Renault is among the early adopters of the technology.
Fortis Solutions, a seasoned enterprise technology partner specializing in infrastructure, cybersecurity, and data systems, views artificial intelligence as a transformative tool that enhances work while maintaining the vital role of human insight. Their approach envisions a future where human decision-making and machine accuracy work together to create innovative opportunities for advancement.
Cash App has launched a new 'pay later' feature for peer-to-peer transfers that includes strong built-in safeguards aimed at preventing users from falling into debt spirals. This responsible approach helps ensure users can manage their payments without accumulating unmanageable debt.
Growth-stage companies often default to hiring from familiar Silicon Valley networks, but truly diverse teams require intentional commitment starting from the very first hire. Founders need to embed this value early on to foster inclusivity within their organization.
Microsoft introduced three advanced AI models developed entirely in-house: a speech transcription system, a voice generation engine, and an enhanced image creator. These models—MAI-Transcribe-1, MAI-Voice-1, and MAI-Image-2—are accessible via Microsoft Foundry and MAI Playground, targeting key enterprise AI needs such as speech-to-text, realistic voice synthesis, and rapid image creation. This launch marks a strategic pivot toward AI self-sufficiency following a contract renegotiation with OpenAI, enabling Microsoft to independently develop frontier AI technologies. Notably, these models demonstrate best-in-class performance, including superior transcription accuracy across 25 languages, and are priced aggressively to undercut competitors like Amazon and Google. Small, agile teams achieved state-of-the-art results using efficient architectures, reducing infrastructure costs. Microsoft aims to continue scaling AI capabilities toward a full-fledged large language model, emphasizing human-centered AI aligned with enterprise needs and governance. This marks a new chapter in Microsoft's AI strategy focused on innovation, efficiency, and market leadership.
Agency trading desks have remained relevant over time, but Horizon Media is stepping up to show how they've matured by developing a unified platform to control ad technology seamlessly from one command center.
American healthcare boasts cutting-edge medical technology, yet patients, especially children with neurological disorders, often endure years of symptom management without clear diagnoses—a journey known as the “diagnostic odyssey.” This process not only saps emotional strength from families and clinicians but also drives up enormous costs. A critical yet underused solution is genomic sequencing, which reads the complete genetic blueprint to pinpoint disease causes. Though clinical guidelines recommend genomic testing early on, it’s frequently delayed, prolonging ineffective treatments and expensive hospital visits. Evidence shows that introducing genomic sequencing earlier can cut healthcare expenses significantly—in epilepsy cases, by up to 61%, saving nearly $80,000 per child annually. This cost reduction reflects a shift from emergency care to focused outpatient management, benefiting Medicaid programs that shoulder much of this financial burden. The core obstacle is not technology but uneven adoption across regions and care settings. For a healthcare system aiming to balance quality and cost, expanding access to genomic sequencing offers a clear pathway to smarter, more effective care. Linda Genen, MD, MPH, Chief Medical Officer at GeneDx, emphasizes that this technology should be a standard part of care everywhere, not a privilege limited by location or resources.
